Cervical CancerNCT02376023
Messages For Your Health: A Cancer Screening Prevention Study
A study testing mHealth in people with Cervical Cancer, run by Pontificia Universidad Catolica de Chile at 2 sites in Chile.
Trial summary
The purpose of this study is to evaluate the implementation and effectiveness of text messages as a means for improving adherence to cervical cancer screening. Read more about this study
- Who is it for?
- Ages 25 to 64 years, women only
- Conditions the study is for
- Cervical Cancer
- What is being tested?
- mHealth
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 400 participants
- Where
- 2 sitesChile
- Study dates
- 22 Feb 2016to Dec 2017
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 25 to 64 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Must have and use a mobile phone
- Enrolled at one of the following clinics: CESFAM El Roble or CESFAM Juan Pablo II.
- Must not have had a Pap test within 3 years or more from recruitment
Who cannot join
- Women who have ever had the diagnosis of cervical cancer.
- Women with a mental or physical disability that inhibits them from understanding the implications of the study or being able to reach the health clinic for an exam.
- Women that are considering relocating within the next year.
Trial locations and contacts
2 sites in 1 country.
Chile2 sites, 2 recruiting
- Recruiting
CESFAM El Roble
Santiago, RM, 8820814
Francis Ciampi, Nurse, 225435479, cesfam_elroble@yahoo.com
- Recruiting
CESFAM Juan Pablo II
Santiago, RM, 8831695
Javiera Martinez-Gutierrez, MD, MPH, 56224822410, jmarting@med.puc.cl
About this study
Official title: Development of Mobile Technologies for the Prevention of Cervical Cancer in Santiago, Chile: A Randomized Controlled Trial.
The purpose of this study is to evaluate the implementation and effectiveness of text messages as a means for improving adherence to cervical cancer screening.
Read the detailed description
- Problem Outline, Theoretical Framework and Project Justification The problem: Cervical Cancer Cervical cancer is a serious public health problem. Worldwide, it is the third leading cause of death of women. An estimated 270,000 women die every year due to cervical cancer, and more than 85% of these deaths take place in developing countries (1). Chile´s national cervical cancer program was created in 1987. Since then, and with the systematic implementation of cervical cancer screening through Papanicolau (Pap) smears, cervical cancer mortality rates have dropped significantly (2,3). In spite of all efforts, cervical cancer continues to cause the mortality of more than 500 women each year in Chile. Across the nation, only 59 percent of the population is up-to-date with their Pap, a figure that has not changed significantly in the last 10 years (2). In the Metropolitan Region, this percentage is as low as 56 percent. The distribution of cervical cancer, like that of other cancers, follows a pattern of inequality in that women of lowest socioeconomic status are those most affected (4). Closing the Gap: Mobile Health (mHealth) Mobile technologies have had an exponential increase in the last few years. In 2014, the penetration of mobile phones will reach 90% in developing countries compared to 121% in developed countries. (5, 6). This same trend can also be seen in access to mobile broadband technologies, which will have an estimated penetration of 32% by the end of 2014. The number of internet users worldwide follows this same trend as well. By the end of 2014, there will be more than 3 billion users, with more than 2/3 of these in developing countries. According to a survey by the Deputy Minister of Telecommunications in Chile (7), access to a mobile or fixed internet connection was 39.4% by the end of 2009. This increased to over 60% by 2012. This coverage is distributed unequally according to socioeconomic class, with more than 81% of penetration in richer homes and less than 30% in poorer strata (21.4% and 9.8% respectively). On the other hand, mobile telephones reached more than 90% of homes in 2009, of both rural and urban survey respondents interviewed by the Deputy Minister of Telecommunications. While inequalities remain in this area as well, they are much less profound than with other technologies: the mobile telephone can be found widely distributed in all socioeconomic levels, and varies between 97% in richer strata and 82.8% in poor SES (7). By the end of 2013, the percentage of mobile telephone subscribers per 100 inhabitants was almost 40% for mobile phones with a contract and more than 94% for phones with prepaid plans. The Solution: Using mobile health technology (mHealth) Mobile health (mHealth) has been defined by the WHO (World Health Organization) as "medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs), and other wireless devices" (9). Given the explosion of the use of these technologies in the world and particularly in developing countries, the potential for mobile health in health issues is huge. The overall interest in mobile health is widespread (11). According to the WHO´s report on mHealth in 2011 (9), mobile health strategies exist in at least 75% of the countries that belong to the WHO in each region. 100% of the countries in the Southeast Asian region reported some mobile health initiative at different stages of development, and the Americas region reported that more than 90% of its countries had some form of mobile health initiative (Chile was not included in these statistics). According to the World Bank, high-income countries reported more initiatives than low-income countries. Some examples of mobile health initiatives in Latin America are the following: Mexico reported a mobile health program called MedicalHome in which a million mobile telephone subscribers have access to health professional support by telephone for $5 per month, which is charged directly to the cell phone account. Columbia reported a program for treatment adherence reminders using voice messages and Peru reported a RCT (Randomized Controlled Trial) that was done to assess treatment adherence using text messaging in patients with HIV/AIDS (9). One of the most relevant problems regarding the use of these technologies is that there isn´t sufficient evidence of its effectiveness in prevention (12). Because of this, it is imperative to invest in rigorous and systematic evaluations of these interventions so that they can be applied at the population level. While some evidence exists that shows that mobile health is an effective strategy for treatment adherence for prenatal care and those with HIV and TB (13,14,15), the potential use of mobile health technologies in cancer prevention has not been fully explored. Given the widespread existence of mobile telephones in Chile, investigators intend with this study to deliver a simple, replicable, and scalable intervention to improve the rates of morbidity and mortality due to cervical cancer that afflict Chile´s population.
- Research Questions
- Do mobile technologies have a preventive benefit in women with greater risk of getting cervical cancer as compared to usual care? 2. In women with greater risk of getting cervical cancer, what are the barriers and facilitators to implementing this kind of technological intervention?
- Research Hypotheses
- Null Hypothesis: The proposed intervention does not increase Pap adherence rates in the studied health centers. Alternative Hypothesis: The proposed intervention increases Pap adherence rates in the studied health centers.
- Null Hypothesis: An intervention using mobile technology cannot be feasibly implemented in this population.
Alternative Hypothesis: It is possible to implement an intervention using mobile technology in this population.
- Study Objectives General Objective: Evaluate the implementation and effectiveness of a mobile health intervention to increase cervical cancer screening adherence.
Specific Objectives:
- Evaluate the effect that a text message intervention has on Pap adherence rates.
- Evaluate the implementation and usability of a cellphone mobile health intervention in three health centers of the Southeast Metropolitan Health District of Santiago.
- Methodology Design:
- Quantitative phase:
- Target Population: Target population will be women between 25 and 64 years of age who use cell phones and do not have an up-to-date Pap test (no Pap in the last three years). They must also be registered at one of the following health clinics: CESFAM (Centro de Salud Familiar) El Roble or CESFAM Juan Pablo II. A randomized controlled trial will be carried out to evaluate the effectiveness of text message intervention in improving Pap adherence. Socio-demographic variables associated with its effectiveness will also be analyzed. Selection methodology: Using the database of medical records in each clinic, women will be identified that meet the inclusion criteria. They will be invited to participate in the study, and if they choose to accept, informed consent will be obtained. Before randomization, the participants will be asked to complete a questionnaire with simple demographic questions and questions regarding their beliefs and attitudes about cellphone use and cervical cancer.
- Randomization: Participants will be randomized into either the intervention group or the control group using a randomization software that keeps the randomization sequence hidden. The control group will receive their usual care in each health center, which consists of different interventions depending on the health center they attend. Examples of usual care include periodic midwife visits, education by health personnel and cervical cancer health campaigns.
- Intervention: Women randomized to the intervention group will receive text and voice messages (designed with input from previous qualitative phase) sent to their cellphones that remind them to get a Pap smear, send them information about cervical cancer, and inform them of health clinic location and hours where they could get a Pap smear.
- Qualitative phase:
The implementation of a mHealth intervention could fail for many reasons. Some of the previously described barriers for this and other types of mobile interventions are: restrictions in the number of characters in the text message, illiteracy, poor signal coverage and quality, and confidentiality and pertinence in families where cellphones are shared.
However, there may be many other factors that hinder or facilitate its effectiveness: lack of funds to keep credit on a cellphone throughout the entire month, losing the phone, little use of text messaging in the elderly, among others.
Investigators will carry out focus groups with women who receive care at the participating centers in order to define barriers and facilitators to a text message intervention that will promote Pap adherence.
Focus Groups Participants:
Women between 25 and 64 years old that meet the inclusion criteria for the study.
Midwives at the health care centers.
Investigators will carry out nine (9) focus groups in total. Women will let us know about barriers and facilitators to the use of this technology and midwives will help investigators to characterize the usual care that women receive and better inform text message content as well as barriers to their use.
Every community member that attends a focus group will receive an incentive of 5,000 Chilean pesos (8 USD) for their time and information. Each health professional that attends a focus group will receive 10,000 Chilean pesos (16 USD).
Data Encoding The focus groups will be led by individuals expert in qualitative methods and assisted by the Principal Investigator and a student assistant who will serve as a note-taker. The focus groups will be recorded for analysis.
The audio of the focus groups will be transcribed and coded using the software Atlas.ti version 6.2
Analysis Information will be analyzed using a qualitative content analysis process* by two or more investigators who will extract relevant themes regarding usage patterns, barriers, and facilitators to this type of intervention. Investigators will use the conceptual framework called PRECEDE-PROCEED in order to carry out the analysis*. Investigators will use it to identify predisposing factors that reinforce and enable the use of mobile technologies to improve Pap adherence.
The collected information will contribute to the design of the intervention, and from there the quantitative phase of the study will begin.
- Sample size Previous studies have shown that without an intervention, around 30% of women who are not up-to-date with their Pap test will get a Pap within the following 6-12 months. Looking at literature regarding similar interventions for other pathologies, investigators anticipate seeing an absolute increase of 15% in adherence rate. With this difference in proportions, and alpha errors of 5% and beta errors of 20%, the estimated sample size is 176 per arm. Considering a loss of 10%, investigators will recruit an estimated 200 patients per arm.
- Statistical Analysis Investigators will use descriptive statistics to characterize demographic variables of the included patients in the same manner as charactering the indicators of implementation.
For the primary outcome (proportion of women with an up-to-date Pap), investigators will use a chi-squared test to test differences in proportions.
For the multivariate analysis, investigators will use logistic regression and Poisson regression.
For the categorical variables, investigators will use a chi-squared test.
- Conditions
- Cervical Cancer
- Being tested
- mHealth
- Keywords
- Cervical Cancer, Women, Latina, Chile, Text Message, Technology, Screening, Cancer Prevention, Health Disparities, Mobile Health
- Medical subject headings
- Uterine Cervical Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
mHealthOther
Text and voice messages sent to study participants reminding them to schedule a PAP smear.
| Study group | Role | What they receive |
|---|---|---|
| mHealth | Experimental | Women in the mHealth group will receive text and voice messages, in addition to their habitual care from the health clinic they attend. The messages will remind them to schedule a PAP smear, and will be sent for 1 year following enrollment in the study. Receives: Other: mHealth |
| No mHealth | No intervention | Women in the No mHealth group will not receive any text messages, and will only receive their habitual care from the health clinic they attend. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of women who received a Pap smear within 6 months from the date when the study randomization began.
The information will be collected from the cancer registration and monitoring database (CITOEXPERT/REVICAN), where Pap data of the population at the national level is registered. Investigators will also review medical records from participating patients at the two health centers. The data collection will take place 6 months after initial recruitment.
Measured: 6 months after randomization of study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Mar 2015 (estimated)
- Study start22 Feb 2016
- Primary completionMay 2017 (estimated)
- Study completionDec 2017 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (17)Papers the sponsor has linked to this study.
- Other trials for Cervical CancerStudies of the same condition, open and under way.
- More trials run by Pontificia Universidad Catolica de ChileThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Care provider, Investigator, Outcomes assessor
- Enrolment
- 400 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Pontificia Universidad Catolica de Chile
- Sponsor type
- University, hospital or other
- Collaborators
- Centro de Salud Familiar El Roble
- Responsible party
- Principal investigator, Javiera Martínez, Pontificia Universidad Catolica de Chile
- Investigators
- Carmen Huerta, Study chair, Comisión Nacional de Investigación Científica y Tecnológica
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02376023
- Sponsor's protocol ID
- CEC Med UC 14-213
- Other IDs
- FONIS ProyectoSA14ID0072
- Status last verified
- Feb 2017
- First submitted
- 17 Feb 2015
- Last updated
- 9 Feb 2017
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- No
Publications
Human papillomavirus (HPV) and cervical cancer. (Updated 2014, November). Retrieved June 4, 2014, from http://www.who.int/mediacentre/factsheets/fs380
Defunciones y mortalidad por causas. (n.d.). Retrieved June 4, 2014, from http://www.deis.cl/?p=2541
Fica A. [Cancer of cervix in Chile. Too much vaccine amid a neglected Papanicolau]. Rev Chilena Infectol. 2014 Apr;31(2):196-203. doi: 10.4067/S0716-10182014000200010. Spanish.
PubMed 24878908Martínez-Bejarano, R & Martínez-Salgado, C. La mortalidad por cáncer cérvico uterino y de mamá en Colombia y Mexico como expresión de las desigualdades socio-económicas y de genero. III Congreso de la Asociación Latinoamericana de Población, ALAP, Córdoba -Argentina, from 24-26 of September 2008. Retrieved June 4, 2014, from http://www.alapop.org/2009/images/DOCSFINAIS_PDF/ALAP _2008_FINAL_155.pdf
Aylward, D., Leão, B., Curioso, W., & Cruz, F. (2010). Can You Heal Me Now? Potential (and Pitfalls) of mHealth. Americas Quarterly, 4(3), 88-95. Retrieved June 4, 2014, from http://www.americasquarterly.org/node/1699
The World in 2014. ICT Facts and Figures. ITU World Telecommunications. Retrieved June 4, 2014, from http://www.itu.int/en/ITU-D/Statistics/Pages/facts/default.aspx
Encuesta Nacional de Consumidores de Servicios de Telecomunicaciones. Subsecretaria de Telecomunicaciones 2014. http://www.subtel.gob.cl/component/search/?searchword=Encuesta%20Nacional&searchphrase=all&Itemid=101
Abonados Móviles [Mobile Subscribers]. (2015, January 9). Retrieved June 4, 2014, from http://www.subtel.gob.cl/informacion-estadistica-actualizada-e-historica4/informacion-estadistica4
MHealth: New Horizons for Health through Mobile Technologies. (2011). Global Observatory for EHealth Series, 3. Retrieved June 4, 2014, from http://www.who.int/goe/publications/goe_mhealth_web.pdf
Green paper on mobile health (mHealth). (2010). European Commission. Retrieved June 4, 2014, from http://ec.europa.eu/digital-agenda/en/news/green-paper-mobile-health-mhealth
Curioso WH, Mechael PN. Enhancing 'M-health' with south-to-south collaborations. Health Aff (Millwood). 2010 Feb;29(2):264-7. doi: 10.1377/hlthaff.2009.1057.
PubMed 20348071Vodopivec-Jamsek V, de Jongh T, Gurol-Urganci I, Atun R, Car J. Mobile phone messaging for preventive health care. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007457. doi: 10.1002/14651858.CD007457.pub2.
PubMed 23235643Curioso WH, Kepka D, Cabello R, Segura P, Kurth AE. Understanding the facilitators and barriers of antiretroviral adherence in Peru: a qualitative study. BMC Public Health. 2010 Jan 13;10:13. doi: 10.1186/1471-2458-10-13.
PubMed 20070889Curioso, W., Gozzer, E., Valderrama, M., Rodriguez-Abad, J., Villena, J., Villena, A. Understanding the potential role of cell phones and the Internet to support care for diabetic patients and caregivers in Peru. AMIA 2009 Symposium Proceedings Page, 805. Retrieved June 4, 2014, from http://faculty.washington.edu/wcurioso/Curioso_Understanding_AMIA_2009.pdf
Curioso, W., Gozzer, E., Valderrama, M., Rodriguez-Abad, J., Villena, J., Villena, A. (2009). Uso y percepciones hacia las tecnologías de información y comunicación en pacientes con diabetes en un hospital público del Perú. [Use and perceptions towards information and communication technologies in patients with diabetes in a Peruvian public hospital]. Rev Per Med Exp Sal Pub, 26(2), 161-67.
Study at a glance
From the registry record, last updated by the sponsor on 9 Feb 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development of Mobile Technologies for the Prevention of Cervical Cancer in Santiago, Chile: A Randomized Controlled Trial.
- ClinicalTrials.gov ID
- NCT02376023
- Acronym / sponsor ID
- CEC Med UC 14-213
- Conditions
- Cervical Cancer
- Keywords
- Cervical Cancer, Women, Latina, Chile, Text Message, Technology, Screening, Cancer Prevention
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Pontificia Universidad Catolica de ChileUniversity, hospital or other
- Collaborators
- Centro de Salud Familiar El Roble
- Study start
- 22 Feb 2016 (actual)
- Primary completion
- May 2017 (estimated)
- Study completion
- Dec 2017 (estimated)
- First posted
- 3 Mar 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to evaluate the implementation and effectiveness of text messages as a means for improving adherence to cervical cancer screening.
Detailed description
- Problem Outline, Theoretical Framework and Project Justification The problem: Cervical Cancer Cervical cancer is a serious public health problem. Worldwide, it is the third leading cause of death of women. An estimated 270,000 women die every year due to cervical cancer, and more than 85% of these deaths take place in developing countries (1). Chile´s national cervical cancer program was created in 1987. Since then, and with the systematic implementation of cervical cancer screening through Papanicolau (Pap) smears, cervical cancer mortality rates have dropped significantly (2,3). In spite of all efforts, cervical cancer continues to cause the mortality of more than 500 women each year in Chile. Across the nation, only 59 percent of the population is up-to-date with their Pap, a figure that has not changed significantly in the last 10 years (2). In the Metropolitan Region, this percentage is as low as 56 percent. The distribution of cervical cancer, like that of other cancers, follows a pattern of inequality in that women of lowest socioeconomic status are those most affected (4). Closing the Gap: Mobile Health (mHealth) Mobile technologies have had an exponential increase in the last few years. In 2014, the penetration of mobile phones will reach 90% in developing countries compared to 121% in developed countries. (5, 6). This same trend can also be seen in access to mobile broadband technologies, which will have an estimated penetration of 32% by the end of 2014. The number of internet users worldwide follows this same trend as well. By the end of 2014, there will be more than 3 billion users, with more than 2/3 of these in developing countries. According to a survey by the Deputy Minister of Telecommunications in Chile (7), access to a mobile or fixed internet connection was 39.4% by the end of 2009. This increased to over 60% by 2012. This coverage is distributed unequally according to socioeconomic class, with more than 81% of penetration in richer homes and less than 30% in poorer strata (21.4% and 9.8% respectively). On the other hand, mobile telephones reached more than 90% of homes in 2009, of both rural and urban survey respondents interviewed by the Deputy Minister of Telecommunications. While inequalities remain in this area as well, they are much less profound than with other technologies: the mobile telephone can be found widely distributed in all socioeconomic levels, and varies between 97% in richer strata and 82.8% in poor SES (7). By the end of 2013, the percentage of mobile telephone subscribers per 100 inhabitants was almost 40% for mobile phones with a contract and more than 94% for phones with prepaid plans. The Solution: Using mobile health technology (mHealth) Mobile health (mHealth) has been defined by the WHO (World Health Organization) as "medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistants (PDAs), and other wireless devices" (9). Given the explosion of the use of these technologies in the world and particularly in developing countries, the potential for mobile health in health issues is huge. The overall interest in mobile health is widespread (11). According to the WHO´s report on mHealth in 2011 (9), mobile health strategies exist in at least 75% of the countries that belong to the WHO in each region. 100% of the countries in the Southeast Asian region reported some mobile health initiative at different stages of development, and the Americas region reported that more than 90% of its countries had some form of mobile health initiative (Chile was not included in these statistics). According to the World Bank, high-income countries reported more initiatives than low-income countries. Some examples of mobile health initiatives in Latin America are the following: Mexico reported a mobile health program called MedicalHome in which a million mobile telephone subscribers have access to health professional support by telephone for $5 per month, which is charged directly to the cell phone account. Columbia reported a program for treatment adherence reminders using voice messages and Peru reported a RCT (Randomized Controlled Trial) that was done to assess treatment adherence using text messaging in patients with HIV/AIDS (9). One of the most relevant problems regarding the use of these technologies is that there isn´t sufficient evidence of its effectiveness in prevention (12). Because of this, it is imperative to invest in rigorous and systematic evaluations of these interventions so that they can be applied at the population level. While some evidence exists that shows that mobile health is an effective strategy for treatment adherence for prenatal care and those with HIV and TB (13,14,15), the potential use of mobile health technologies in cancer prevention has not been fully explored. Given the widespread existence of mobile telephones in Chile, investigators intend with this study to deliver a simple, replicable, and scalable intervention to improve the rates of morbidity and mortality due to cervical cancer that afflict Chile´s population.
- Research Questions
- Do mobile technologies have a preventive benefit in women with greater risk of getting cervical cancer as compared to usual care? 2. In women with greater risk of getting cervical cancer, what are the barriers and facilitators to implementing this kind of technological intervention?
- Research Hypotheses
- Null Hypothesis: The proposed intervention does not increase Pap adherence rates in the studied health centers. Alternative Hypothesis: The proposed intervention increases Pap adherence rates in the studied health centers.
- Null Hypothesis: An intervention using mobile technology cannot be feasibly implemented in this population.
Alternative Hypothesis: It is possible to implement an intervention using mobile technology in this population.
- Study Objectives General Objective: Evaluate the implementation and effectiveness of a mobile health intervention to increase cervical cancer screening adherence.
Specific Objectives:
- Evaluate the effect that a text message intervention has on Pap adherence rates.
- Evaluate the implementation and usability of a cellphone mobile health intervention in three health centers of the Southeast Metropolitan Health District of Santiago.
- Methodology Design:
- Quantitative phase:
- Target Population: Target population will be women between 25 and 64 years of age who use cell phones and do not have an up-to-date Pap test (no Pap in the last three years). They must also be registered at one of the following health clinics: CESFAM (Centro de Salud Familiar) El Roble or CESFAM Juan Pablo II. A randomized controlled trial will be carried out to evaluate the effectiveness of text message intervention in improving Pap adherence. Socio-demographic variables associated with its effectiveness will also be analyzed. Selection methodology: Using the database of medical records in each clinic, women will be identified that meet the inclusion criteria. They will be invited to participate in the study, and if they choose to accept, informed consent will be obtained. Before randomization, the participants will be asked to complete a questionnaire with simple demographic questions and questions regarding their beliefs and attitudes about cellphone use and cervical cancer.
- Randomization: Participants will be randomized into either the intervention group or the control group using a randomization software that keeps the randomization sequence hidden. The control group will receive their usual care in each health center, which consists of different interventions depending on the health center they attend. Examples of usual care include periodic midwife visits, education by health personnel and cervical cancer health campaigns.
- Intervention: Women randomized to the intervention group will receive text and voice messages (designed with input from previous qualitative phase) sent to their cellphones that remind them to get a Pap smear, send them information about cervical cancer, and inform them of health clinic location and hours where they could get a Pap smear.
- Qualitative phase:
The implementation of a mHealth intervention could fail for many reasons. Some of the previously described barriers for this and other types of mobile interventions are: restrictions in the number of characters in the text message, illiteracy, poor signal coverage and quality, and confidentiality and pertinence in families where cellphones are shared.
However, there may be many other factors that hinder or facilitate its effectiveness: lack of funds to keep credit on a cellphone throughout the entire month, losing the phone, little use of text messaging in the elderly, among others.
Investigators will carry out focus groups with women who receive care at the participating centers in order to define barriers and facilitators to a text message intervention that will promote Pap adherence.
Focus Groups Participants:
Women between 25 and 64 years old that meet the inclusion criteria for the study.
Midwives at the health care centers.
Investigators will carry out nine (9) focus groups in total. Women will let us know about barriers and facilitators to the use of this technology and midwives will help investigators to characterize the usual care that women receive and better inform text message content as well as barriers to their use.
Every community member that attends a focus group will receive an incentive of 5,000 Chilean pesos (8 USD) for their time and information. Each health professional that attends a focus group will receive 10,000 Chilean pesos (16 USD).
Data Encoding The focus groups will be led by individuals expert in qualitative methods and assisted by the Principal Investigator and a student assistant who will serve as a note-taker. The focus groups will be recorded for analysis.
The audio of the focus groups will be transcribed and coded using the software Atlas.ti version 6.2
Analysis Information will be analyzed using a qualitative content analysis process* by two or more investigators who will extract relevant themes regarding usage patterns, barriers, and facilitators to this type of intervention. Investigators will use the conceptual framework called PRECEDE-PROCEED in order to carry out the analysis*. Investigators will use it to identify predisposing factors that reinforce and enable the use of mobile technologies to improve Pap adherence.
The collected information will contribute to the design of the intervention, and from there the quantitative phase of the study will begin.
- Sample size Previous studies have shown that without an intervention, around 30% of women who are not up-to-date with their Pap test will get a Pap within the following 6-12 months. Looking at literature regarding similar interventions for other pathologies, investigators anticipate seeing an absolute increase of 15% in adherence rate. With this difference in proportions, and alpha errors of 5% and beta errors of 20%, the estimated sample size is 176 per arm. Considering a loss of 10%, investigators will recruit an estimated 200 patients per arm.
- Statistical Analysis Investigators will use descriptive statistics to characterize demographic variables of the included patients in the same manner as charactering the indicators of implementation.
For the primary outcome (proportion of women with an up-to-date Pap), investigators will use a chi-squared test to test differences in proportions.
For the multivariate analysis, investigators will use logistic regression and Poisson regression.
For the categorical variables, investigators will use a chi-squared test.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| mHealth | Experimental | Other: mHealthWomen in the mHealth group will receive text and voice messages, in addition to their habitual care from the health clinic they attend. The messages will remind them to schedule a PAP smear, and will be sent for 1 year following enrollment in the study. |
| No mHealth | No intervention | –Women in the No mHealth group will not receive any text messages, and will only receive their habitual care from the health clinic they attend. |
Who may qualify
- Ages
- 25 to 64 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Must have and use a mobile phone
- Enrolled at one of the following clinics: CESFAM El Roble or CESFAM Juan Pablo II.
- Must not have had a Pap test within 3 years or more from recruitment
Key exclusion criteria (3 listed)
- Women who have ever had the diagnosis of cervical cancer.
- Women with a mental or physical disability that inhibits them from understanding the implications of the study or being able to reach the health clinic for an exam.
- Women that are considering relocating within the next year.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| mHealthText and voice messages sent to study participants reminding them to schedule a PAP smear. | Other | mHealth |
Primary outcome
Proportion of women who received a Pap smear within 6 months from the date when the study randomization began.
Time frame: 6 months after randomization of study
The information will be collected from the cancer registration and monitoring database (CITOEXPERT/REVICAN), where Pap data of the population at the national level is registered. Investigators will also review medical records from participating patients at the two health centers. The data collection will take place 6 months after initial recruitment.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Feb 2017.
- BackgroundHuman papillomavirus (HPV) and cervical cancer. (Updated 2014, November). Retrieved June 4, 2014, from http://www.who.int/mediacentre/factsheets/fs380
- BackgroundDefunciones y mortalidad por causas. (n.d.). Retrieved June 4, 2014, from http://www.deis.cl/?p=2541
- Background: PubMed 24878908Fica A. [Cancer of cervix in Chile. Too much vaccine amid a neglected Papanicolau]. Rev Chilena Infectol. 2014 Apr;31(2):196-203. doi: 10.4067/S0716-10182014000200010. Spanish.
- BackgroundMartínez-Bejarano, R & Martínez-Salgado, C. La mortalidad por cáncer cérvico uterino y de mamá en Colombia y Mexico como expresión de las desigualdades socio-económicas y de genero. III Congreso de la Asociación Latinoamericana de Población, ALAP, Córdoba -Argentina, from 24-26 of September 2008. Retrieved June 4, 2014, from http://www.alapop.org/2009/images/DOCSFINAIS_PDF/ALAP _2008_FINAL_155.pdf
- BackgroundAylward, D., Leão, B., Curioso, W., & Cruz, F. (2010). Can You Heal Me Now? Potential (and Pitfalls) of mHealth. Americas Quarterly, 4(3), 88-95. Retrieved June 4, 2014, from http://www.americasquarterly.org/node/1699
- BackgroundThe World in 2014. ICT Facts and Figures. ITU World Telecommunications. Retrieved June 4, 2014, from http://www.itu.int/en/ITU-D/Statistics/Pages/facts/default.aspx
- BackgroundEncuesta Nacional de Consumidores de Servicios de Telecomunicaciones. Subsecretaria de Telecomunicaciones 2014. http://www.subtel.gob.cl/component/search/?searchword=Encuesta%20Nacional&searchphrase=all&Itemid=101
- BackgroundAbonados Móviles [Mobile Subscribers]. (2015, January 9). Retrieved June 4, 2014, from http://www.subtel.gob.cl/informacion-estadistica-actualizada-e-historica4/informacion-estadistica4
- BackgroundMHealth: New Horizons for Health through Mobile Technologies. (2011). Global Observatory for EHealth Series, 3. Retrieved June 4, 2014, from http://www.who.int/goe/publications/goe_mhealth_web.pdf
- BackgroundGreen paper on mobile health (mHealth). (2010). European Commission. Retrieved June 4, 2014, from http://ec.europa.eu/digital-agenda/en/news/green-paper-mobile-health-mhealth
- Background: PubMed 20348071Curioso WH, Mechael PN. Enhancing 'M-health' with south-to-south collaborations. Health Aff (Millwood). 2010 Feb;29(2):264-7. doi: 10.1377/hlthaff.2009.1057.
- Background: PubMed 23235643Vodopivec-Jamsek V, de Jongh T, Gurol-Urganci I, Atun R, Car J. Mobile phone messaging for preventive health care. Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD007457. doi: 10.1002/14651858.CD007457.pub2.
- Individual participant dataSharing planned: No
Related trials for Cervical Cancer
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingObservational study
Proton Re-irradiation in Patients With Recurrent or Second Primary Head and Neck Cancer , a Multicentre Phase II Single Arm Trial
Head & Neck Cancer
RecruitingPhase 2/3
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Oesophageal Cancer, Gastric Cancer
RecruitingPhase 2
Proton Spatially Fractionated Radiotherapy or Photon Stereotactic Body Radiotherapy in Combination With Pembrolizumab Before Surgery for the Treatment of Locally Advanced and Radiation-Naive Locoregionally Recurrent Oral Cavity Cancer, OSPRI Trial
Locally Advanced Oral Cavity Squamous Cell Carcinoma, Locally Recurrent Oral Cavity Squamous Cell Carcinoma
RecruitingPhase 4
Lidocaine Infiltration and Neuroimmunomodulation in Head and Neck Cancer Surgery
Head and Neck Cancer (H&N)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Carmen Huerta study chair
Comisión Nacional de Investigación Científica y Tecnológica
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing mHealth in people with Cervical Cancer, run by Pontificia Universidad Catolica de Chile at 2 sites in Chile.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 9 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Javiera Martínez, MD, MPH ((56) 23548688, jmarting@med.puc.cl), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of women who received a Pap smear within 6 months from the date when the study randomization began. (time frame: 6 months after randomization of study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02376023, which also lists 17 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Feb 2017.